Biopatología de la membrana sinovial en la artritis psoriásica

Fitzgerald, 2009, Psoriatic arthritis: from pathogenesis to therapy, Arthritis Res Ther, 11, 214, 10.1186/ar2580 O’Rielly, 2011, Genetics of susceptibility and treatment response in psoriatic arthritis, Nat Rev Rheumatol, 71, 8 Plenge, 2009, Rheumatoid arthritis genetics: 2009 update, Curr Rheumatol Rep, 11, 351, 10.1007/s11926-009-0050-0 Saber, 2010, Remission in psoriatic arthritis: is it possible and how can it be predicted?, Arthritis Res Ther, 12, R94, 10.1186/ar3021 McGonagle, 2006, A proposed classification of the immunological diseases, PLoS Med, 3, e297, 10.1371/journal.pmed.0030297 Bugatti, 2011, Synovial tissue heterogeneity and peripheral blood biomarkers, Curr Rheumatol Rep, 13, 440, 10.1007/s11926-011-0201-y Kruithof, 2005, Synovial histopathology of psoriatic arthritis, both oligo- and polyarticular, resembles spondyloarthropathy more than it does rheumatoid arthritis, Arthritis Res Ther, 7, R569, 10.1186/ar1698 McGonagle, 2007, The concept of a synovio-entheseal complex and its implications for understandingunderstanding joint inflammation and damage in psoriatic arthritis and beyond, Arthritis Rheum, 56, 2482, 10.1002/art.22758 Cañete, 2005, Sinovitis psoriásica: implicaciones patogénicas y terapéuticas, Reumatol Clin, 1, 218, 10.1016/S1699-258X(05)72747-9 Reece, 1999, Distinct vascular patterns of early synovitis in psoriatic, reactive and psoriatic arthritis, Arthritis Rheum, 42, 1481, 10.1002/1529-0131(199907)42:7<1481::AID-ANR23>3.0.CO;2-E Cañete, 2003, Diagnostic usefulness of synovial vascular morphology in chronic artritis. A systematic survey of 100 cases, Semin Arthritis Rheum, 32, 378, 10.1053/sarh.2002.50004 Baeten, 2000, Comparative study of the synovial histology in rheumatoid arthritis, spondyloarthropathy, and osteoarthritis: influence of disease duration and activity, Ann Rheum Dis, 59, 945, 10.1136/ard.59.12.945 Fassbender, 2002 Veale, 1993, Reduced synovial membrane macrophage numbers, ELAM-1 expression, and lining layer hyperplasia in psoriatic arthritis as compared with rheumatoid arthritis, Arthritis Rheum, 36, 89, 10.1002/art.1780360705 Danning, 2000, Macrophage-derived cytokine and nuclear factor kappaB p65 expression in synovial membrane and skin of patient with psoriatic arthritis, Arthritis Rheum, 43, 1244, 10.1002/1529-0131(200006)43:6<1244::AID-ANR7>3.0.CO;2-2 Fraser, 2001, Matrix metalloproteinase 9, apoptosis, and vascular morphology in early arthritis, Arthritis Rheum, 44, 2024, 10.1002/1529-0131(200109)44:9<2024::AID-ART351>3.0.CO;2-K Fearon, 2003, Angiopoietins, growth factors, and vascular morphology in early arthritis, J Rheumatol, 30, 260 Cañete, 2004, Antiangiogenic effects of anti-tumor necrosis factor alpha therapy with infliximab in psoriatic arthritis, Arthritis Rheum, 50, 1636, 10.1002/art.20181 Goedkoop, 2004, Deactivation of endothelium and reduction in angiogenesis in psoriatic skin and synovium by low dose infliximab therapy in combination with stable methotrexate therapy: a prospective single-centre study, Arthritis Res Ther, 6, R326, 10.1186/ar1182 Cantaert, 2008, B lymphocyte autoimmunity in rheumatoid synovitis is independent of ectopic lymphoid neogenesis, J Immunol, 181, 785, 10.4049/jimmunol.181.1.785 Humby, 2009, Ectopic lymphoid structures support ongoing production of class-switched autoantibodies in rheumatoid synovium, PLoS Med, 6, e1, 10.1371/journal.pmed.0060001 Thurlings, 2008, Synovial lymphoid neogenesis does not define a specific clinical rheumatoid arthritis phenotype, Arthritis Rheum, 58, 1582, 10.1002/art.23505 Cañete, 2009, Clinical significance of synovial lymphoid neogenesis and its reversal after anti-tumour necrosis factor alpha therapy in rheumatoid arthritis, Ann Rheum Dis, 68, 751, 10.1136/ard.2008.089284 Cañete, 2010, Lymphoid aggregation is not lymphoid neogenesis: comment on the article by Klaasen et al, Arthritis Rheum, 62, 2825, 10.1002/art.27563 Cañete, 2007, Ectopic lymphoid neogenesis in psoriatic arthritis, Ann Rheum Dis, 66, 720, 10.1136/ard.2006.062042 Del Rey MJ, Usategui A, Izquierdo E, Cañete JD, Blanco FJ, Criado G, et al. Transcriptome analysis reveals specific changes in osteoarthritis synovial fibroblasts. Ann Rheum Dis. 2012;71:275-80. Izquierdo, 2011, Synovial fibroblast hyperplasia in rheumatoid arthritis: clinicopathologic correlations and partial reversal by anti-tumor necrosis factor therapy, Arthritis Rheum, 63, 2575, 10.1002/art.30433 Izquierdo, 2009, Immature blood vessels in rheumatoid synovium are selectively depleted in response to anti-TNF Therapy, PLoS One, 4, e8131, 10.1371/journal.pone.0008131 Baeten, 2006, Synovial inflammation does not change in the absence of effective treatment: implications for the use of synovial histopathology as biomarker in early phase clinical trials in rheumatoid arthritis, Ann Rheum Dis, 65, 990, 10.1136/ard.2005.047852 Salvador, 2005, p53 expression in rheumatoid and psoriatic arthritis synovial tissue and association with joint damage, Ann Rheum Dis, 64, 183, 10.1136/ard.2004.024430 Kruithof, 2006, Identification of synovial biomarkers of response to experimental treatment in early-phase clinical trials in spondylarthritis, Arthritis Rheum, 54, 1795, 10.1002/art.21914 Vandooren, 2009, Absence of a classically activated macrophage cytokine signature in peripheral spondylarthritis, including psoriatic arthritis, Arthritis Rheum, 60, 966, 10.1002/art.24406 Baeten, 2004, Association of CD163+ macrophages and local production of soluble CD163 with decreased lymphocyte activation in spondylarthropathy synovitis, Arthritis Rheum, 50, 1611, 10.1002/art.20174 Sigal, 2011, Basic science for the clinician 53: mast cells, J Clin Rheumatol, 17, 395, 10.1097/RHU.0b013e31823150b5 Cañete, 2009, Distinct synovial immunopathology in Behçet disease and psoriatic arthritis, Arthritis Res Ther, 11, R17, 10.1186/ar2608 Noordenbos T, Yeremenko N, Gofita I, Van de Sande M, Tak PP, Caňete JD, et al. IL-17 positive mast cells contribute to synovial inflammation in spondyloarthritis. Arthritis Rheum. 2012;64:99-109. Hueber, 2010, Mast cells express IL-17A in rheumatoid arthritis synovium, J Immunol, 184, 3336, 10.4049/jimmunol.0903566 Lin, 2011, Mast cells and neutrophils release IL-17 through extracellular trap formation in psoriasis, J Immunol, 187, 490, 10.4049/jimmunol.1100123 Appel, 2011, Analysis of IL-17+ cells in facet joints of patients with spondyloarthritis suggests that the innate immune pathway might be of greater relevance than the Th17-mediated adaptive immune response, Arthritis Res Ther, 13, R95, 10.1186/ar3370 Yeremenko, 2011, IL-17 in spondyloarthritis: is the T-party over?, Arthritis Res Ther, 13, 115, 10.1186/ar3351 Van Kuijk, 2011, Synovitis in psoriatic arthritis: immunohistochemistry, comparisons with rheumatoid arthritis, and effects of Therapy, Curr Rheumatol Rep, 13, 353, 10.1007/s11926-011-0181-y Ritchlin, 2003, Mechanisms of TNF-alpha- and RANKL-mediated osteoclastogenesis and bone resorption in psoriatic arthritis, J Clin Invest, 111, 821, 10.1172/JCI200316069